Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.
Molecular Weight:
473.37
Purity:
>99.0%
CAS Number:
[1446502-11-9]
Formula:
C19H17F6N7O
Target:
Isocitrate Dehydrogenase (IDH)
* VAT and and shipping costs not included. Errors and price changes excepted
